Video: Closure of Kabco Shows FDA's PowerVideo: Closure of Kabco Shows FDA's Power
May 15, 2013
FDA ordered contract manufacturer Kabco Pharmaceuticals to halt production of dietary supplements until it proves its facilities are compliant with GMPs (good manufacturing practices). This follows a warning letter FDA sent the company in 2010 regarding its GMP violations. Anthony Young an attorney at Kleinfeld, Kaplan and Becker, reviewed the consent degree provides some perspective from the SupplySide MarketPlace show floor.
You May Also Like
Sep 28, 2023
Unlocking vitality: The power of mineral-enriched gummies – articleSep 27, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023